Clinical Outcome of CT-Guided Stereotactic Ablative Brachytherapy for Unresectable Early Non-Small Cell Lung Cancer: A Retrospective, Multicenter Study

OBJECTIVE: To analyze the efficacy and safety of low dose rate stereotactic ablative brachytherapy (L-SABT) for treatment of unresectable early-stage non-small cell lung cancer (NSCLC). METHODS: Data of patients with early-stage NSCLC who received CT-guided L-SABT (radioactive I-125 seeds implantati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Zhe, Huo, Bin, Liu, Shifeng, Liang, Qinghua, Xing, Chao, Hu, Miaomiao, Ma, Yanli, Wang, Zhe, Zhao, Xinxin, Song, Yuqing, Wang, Yufeng, Han, Hongmei, Zhang, Kaixian, Wang, Ruoyu, Chai, Shude, Huang, Xuequan, Hu, Xiaokun, Wang, Junjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480264/
https://www.ncbi.nlm.nih.gov/pubmed/34604042
http://dx.doi.org/10.3389/fonc.2021.706242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480264/
https://www.ncbi.nlm.nih.gov/pubmed/34604042
http://dx.doi.org/10.3389/fonc.2021.706242

Ejemplares similares